elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35456745-2711A9C6-66A5-40C7-AE67-7E878787CF20
Q35456745-2711A9C6-66A5-40C7-AE67-7E878787CF20
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35456745-2711A9C6-66A5-40C7-AE67-7E878787CF20
The catechol-O-methyltransferase (COMT) inhibitor entacapone enhances the pharmacokinetic and clinical response to Sinemet CR in Parkinson's disease
P2860
Q35456745-2711A9C6-66A5-40C7-AE67-7E878787CF20
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35456745-2711A9C6-66A5-40C7-AE67-7E878787CF20
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4ed25add6c81c46f61f5c92f49d62128c8b8a161
P2860
Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography.